The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Delineating the role of the microbiome and tumor microenvironment interactions driving mucosal melanoma (MM) response and resistance to immune checkpoint inhibitor (ICI) treatment.
 
Florentia Dimitriou
No Relationships to Disclose
 
Ashish Damania
No Relationships to Disclose
 
Priyadharsini Nagarajan
No Relationships to Disclose
 
Sabitha Prabhakaran
No Relationships to Disclose
 
Pranoti Sahasrabhojane
No Relationships to Disclose
 
Yasmine Hoballah
No Relationships to Disclose
 
Devarati Mitra
No Relationships to Disclose
 
Roi Weiser
No Relationships to Disclose
 
Shirley Su
Stock and Other Ownership Interests - CSL Limited; Intellia Therapeutics; ResMed
Travel, Accommodations, Expenses - Medtronic
 
Ehab Hanna
No Relationships to Disclose
 
Bita Esmaeli
No Relationships to Disclose
 
Travis Sims
Research Funding - Bristol Myers Squibb Foundation; Gilead Sciences; NIH (Inst)
 
Curtis Pettaway
Consulting or Advisory Role - Wolters Kluwer
Speakers' Bureau - Wolters Kluwer
(OPTIONAL) Uncompensated Relationships - EAU-ASCO Penile Cancer Guidelines Panel
 
Rodabe Amaria
Consulting or Advisory Role - Erasca, Inc; IO Biotech; KSQ Therapeutics; Obsidian Therapeutics; Replimune
Research Funding - Bristol-Myers Squibb (Inst); Erasc (Inst); Genentech (Inst); iovance Biotherapeutics (Inst); KSQ Therapeutics (Inst); Novartis (Inst); Obsidian Therapeutics (Inst); OnKure (Inst); Regeneron (Inst)
 
Isabella Glitza
Honoraria - Amgen
Consulting or Advisory Role - Array BioPharma; Bristol-Myers Squibb; Leal Therapeutics; Midatech Pharma; Novartis; Sintetica
Speakers' Bureau - Array BioPharma
Research Funding - Bristol-Myers Squibb (Inst); Merck (Inst); Pfizer (Inst)
 
Nadim Ajami
No Relationships to Disclose
 
Scott Woodman
No Relationships to Disclose
 
Jennifer Wargo
Stock and Other Ownership Interests - Micronoma
Honoraria - Daiichi Sankyo/UCB Japan; EverImmune; Gustave Roussy Cancer Center; OSE Immunotherapeutics; Peerview
Consulting or Advisory Role - Daiichi Sankyo/UCB Japan; EverImmune; Gustave Roussy Cancer Center; OSE Immunotherapeutics; Peerview
Patents, Royalties, Other Intellectual Property - Patent submitted regarding the role of the microbiome in response to immune checkpoint blockade
Travel, Accommodations, Expenses - Gustave Roussy Cancer Center; Peerview
 
Phillip Futreal
Stock and Other Ownership Interests - Scorpion Therapeutics
Consulting or Advisory Role - GenePlus; Lepidyne; Scorpion Therapeutics
 
Jennifer McQuade
Honoraria - Bristol-Myers Squibb; Merck; Roche
Consulting or Advisory Role - Bristol Myer Squibb; Roche Pharma AG
Travel, Accommodations, Expenses - Merck